Lifespan Cancer Institute is a clinical research site located in Providence, Rhode Island, United States 02905.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Lifespan Cancer Institute has participated in 30 clinical trials with 19 currently active.
Therapeutic areas: B-cell Non-Hodgkin Lymphoma, Metastatic Castration-resistant Prostate Cancer, Non-Hodgkin Lymphoma, Follicular Lymphoma.
Sponsors: Hoffmann-La Roche, Brown University, Eikon Therapeutics.
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lifespan Cancer Institute has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lifespan Cancer Institute has 30 clinical trials on record, with 19 currently active. Their work covers B-cell Non-Hodgkin Lymphoma, Metastatic Castration-resistant Prostate Cancer, Non-Hodgkin Lymphoma, Follicular Lymphoma.
Lifespan Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.